Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
23 participants
OBSERVATIONAL
2017-06-09
2017-09-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Skeletal Muscle Wasting in ICU Patients
NCT06234826
Nutritional Status, Muscle Wasting and Fraility in Intensive Care Patients
NCT04709198
Body Composition Study in Critically Ill Patients
NCT04262531
Muscle Mass Loss in Critically Ill Patients.
NCT03865095
Biomechanical Properties in Intensive Care Unit (ICU) Survivors 12-month After Discharge
NCT01364714
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this observational study we try to measure muscle mass and body composition by echocardiography and BIVA at admission and on day 2, 5
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
muscle mass measurement
measurement of muscle mass by echocardiography
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* stay on ICU \< 48 hours
* use of corticosteroids
* neurological diseases
* acute kidney injure / nead of CVVH
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Frisius Medisch Centrum
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Matty Koopmans
research coordinator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matty Koopmans, MSc
Role: PRINCIPAL_INVESTIGATOR
MCL
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical Center Leeuwarden
Leeuwarden, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
nWMO 205
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.